Back to Trades
Sell4
Rapport Therapeutics, Inc.
RAPP
Total Value
$275.0K
Net $275.0K sold
Sales
$275.0K
4 transactions
Company Information
- Company Name
- Rapport Therapeutics, Inc.
- Ticker Symbol
- RAPP
- CIK
- 0002012593
Insider Information
- Name
- Ceesay Abraham
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Nov 18, 2025
- Transaction Date
- Nov 17, 2025
- Accession Number
- 0001193125-25-286218
- Form Type
- 4
- Net Trading Amount
- -$275.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock | 2,777 | $24.92 | Sale | $69.2K |
| Nov 17, 2025 | Common Stock | 3,056 | $25.43 | Sale | $77.7K |
| Nov 17, 2025 | Common Stock | 2,242 | $24.91 | Sale | $55.8K |
| Nov 17, 2025 | Common Stock | 2,841 | $25.44 | Sale | $72.3K |
Footnotes
- (F1)These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024.
- (F2)The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.22 to $25.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- (F3)The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.22 to $25.68 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- (F4)The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.21 to $25.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- (F5)Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- (F6)The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.23 to $25.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- (F7)Shares held by The Ceesay Family Irrevocable Trust u/t/d March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.